Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

A phase i clinical trial of the hu14.18-il2 (emd 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: A study of the children's oncology group

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Osenga, K. L.
  • Hank, J. A.
  • Albertini, M. R.
  • Gan, J.
  • Sternberg, A. G.
  • Eickhoff, J.
  • Seeger, R. C.
  • Matthay, K. K.
  • Reynolds, C. P.
  • Twist, C.
  • Krailo, M.
  • Adamson, P. C.
  • Reisfeld, Ralph
  • Gillies, S. D.
  • Sondel, P. M.

publication date

  • March 2006

journal

  • Clinical Cancer Research  Journal

subject areas

  • Adolescent
  • Anemia
  • Antibodies
  • Antibodies, Monoclonal
  • Area Under Curve
  • Child
  • Child, Preschool
  • Dose-Response Relationship, Drug
  • Drug Resistance, Neoplasm
  • Female
  • Fever
  • Humans
  • Hypotension
  • Infusions, Intravenous
  • Interleukin-2
  • Male
  • Melanoma
  • Metabolic Clearance Rate
  • Neoplasm Recurrence, Local
  • Neuroblastoma
  • Treatment Outcome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 1078-0432

Digital Object Identifier (DOI)

  • 10.1158/1078-0432.ccr-05-2000

PubMed ID

  • 16551859
scroll to property group menus

Additional Document Info

start page

  • 1750

end page

  • 1759

volume

  • 12

issue

  • 6

©2021 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support